NCT07600697: Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery
- State
- Not started
- Phase
- Phase 4
- People
- 120 planned
- Started
- 1 Nov 2026
- Primary completion
- 1 Jul 2027
- Arms
- Suzetrigine-Based Regimen
- Results
- None posted
- 22 May 2026: Trial registered